US Broker Ratings

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Unpacking a 246% Potential Upside Opportunity

Heron Therapeutics, Inc. (NASDAQ: HRTX) presents a compelling opportunity for investors eyeing the biotechnology sector. With a market capitalization of approximately $279.19 million, Heron Therapeutics stands..

National Research Corporation (NRC) Stock Analysis: A High ROE Healthcare Play with a Compelling Dividend Yield

National Research Corporation (NASDAQ: NRC) stands out in the healthcare sector, primarily due to its comprehensive suite of analytics and insights solutions designed to enhance patient..

Candel Therapeutics, Inc. (CADL) Stock Analysis: An Exciting 264.76% Potential Upside in Cancer Immunotherapy

Candel Therapeutics, Inc. (NASDAQ: CADL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its promising portfolio of cancer immunotherapies. With a market..

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Is There More Room to Grow Beyond Its 2.44% Potential Upside?

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is garnering attention in the biotechnology sector, a segment known for its innovation and potential high returns. As a commercial-stage immunotherapy..

ClearPoint Neuro Inc. (CLPT) Investor Outlook: Exploring a Potential 139% Upside in the Medical Device Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) has emerged as a compelling player in the healthcare sector, specifically within the niche of medical devices. With a market capitalization..

Spok Holdings, Inc. (SPOK) Stock Analysis: High Dividend Yield and a Promising 23.61% Upside

Spok Holdings, Inc. (NASDAQ: SPOK), a leader in healthcare communication solutions, is capturing attention with its attractive dividend yield and potential price upside. With a market..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Unpacking a 297.87% Potential Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is carving its niche in the biotechnology sector with an ambitious focus on mRNA cell therapies targeting autoimmune diseases. As a..

Anbio Biotechnology (NNNN) Stock Analysis: A Promising Growth Story Amidst a Challenging Year

Anbio Biotechnology, trading under the ticker symbol NNNN, represents a compelling opportunity within the healthcare sector, specifically in the medical instruments and supplies industry. Headquartered in..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unpacking a 398% Potential Upside in the Biotech Sector

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a clinical-stage biopharmaceutical entity focused on pioneering treatments for women’s cancers, presents a compelling investment case in the biotechnology sector. Despite..

Arcturus Therapeutics Holdings (ARCT): Biotech Stock with a 465% Upside – Is It Worth the Risk?

For investors with an appetite for high-risk, high-reward opportunities, Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) presents a compelling case. This San Diego-based biotech company, specializing in..

Senseonics Holdings, Inc. (SENS): Investor Outlook on Its 276% Potential Upside

For investors eyeing the healthcare sector, Senseonics Holdings, Inc. (SENS) presents a compelling opportunity with its significant potential upside of 276.93%. Specializing in continuous glucose monitoring..

Outset Medical, Inc. (OM) Stock Analysis: Exploring the 23% Potential Upside in Healthcare Innovation

Outset Medical, Inc. (NASDAQ: OM), a pioneering player in the healthcare sector, is capturing the attention of investors with its innovative medical devices and promising market..

Nano-X Imaging Ltd (NNOX) Stock Analysis: A Glimpse Into Its 69.90% Potential Upside

Nano-X Imaging Ltd (NASDAQ: NNOX), a healthcare company at the forefront of medical imaging technology, presents a compelling investment opportunity with a tantalizing 69.90% potential upside...

TruBridge, Inc. (TBRG) Stock Analysis: Investor Outlook with a 22.90% Potential Upside

TruBridge, Inc. (TBRG) is emerging as a noteworthy player in the healthcare information services sector. With its headquarters in Mobile, Alabama, TruBridge offers an array of..

Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Exploring a 75.83% Potential Upside in the Biotech Sector

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is making waves in the biotechnology sector with its innovative therapies targeting hematologic disorders and cancer. With a market capitalization of..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Opportunities in the Veterinary Vaccine Market

Zhengye Biotechnology Holding Limited (ZYBT) is carving a niche in the healthcare sector as a specialized player in the veterinary vaccine industry. Operating out of Jilin,..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Exploring a 254% Potential Upside in Biotech

Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology industry with its innovative approach to RNA medicine, as highlighted by its robust development..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Navigating a 5.63% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) operates at the intersection of healthcare and facility management, providing essential services to a broad range of medical care facilities..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 31.10% Potential Upside Amidst Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a key player in the healthcare sector, specializing in medical devices. This U.S.-based company has carved a niche in..

Harrow, Inc. (HROW) Stock Analysis: Exploring 100% Potential Upside in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW), a prominent player in the eyecare pharmaceutical industry, has recently caught the attention of investors with its promising growth prospects. The company,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds